Puravankara Ltd
BSE:532891
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Puravankara Ltd
BSE:532891
|
IN |
|
Keppel DC REIT
OTC:KPDCF
|
SG |
|
Atos SE
F:AXI1
|
FR |
|
T
|
Telo Genomics Corp
OTC:TDSGF
|
CA |
|
M
|
Medical Properties Trust Inc
SWB:M3P
|
US |
|
Grenke AG
F:GLJ
|
DE |
|
A
|
AXA SA
DUS:AXA
|
FR |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PURVA's stock price target?
Not Available
PURVA does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Puravankara Ltd?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 2 years is 5%.
What is the Gross Profit forecast for Puravankara Ltd?
Projected CAGR
-21%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 9 years is -21%.
What is the Operating Income forecast for Puravankara Ltd?
Projected CAGR
20%
Over the last 14 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 2 years is 20%.
What is the Pre-Tax Income forecast for Puravankara Ltd?
Projected CAGR
159%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been -6%. The projected CAGR for the next 2 years is 159%.
What is the Net Income forecast for Puravankara Ltd?
Projected CAGR
131%
Over the last 14 years, the compound annual growth rate for Net Income has been -5%. The projected CAGR for the next 2 years is 131%.
